110 related articles for article (PubMed ID: 10341290)
1. Receptor-mediated interleukin-2 gene transfer into human hepatoma cells.
Junbo H; Li Q; Zaide W; Yunde H
Int J Mol Med; 1999 Jun; 3(6):601-8. PubMed ID: 10341290
[TBL] [Abstract][Full Text] [Related]
2. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated histone-mediated gene transfer and expression.
Chen J; Stickles RJ; Daichendt KA
Hum Gene Ther; 1994 Apr; 5(4):429-35. PubMed ID: 8049301
[TBL] [Abstract][Full Text] [Related]
4. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).
Sun X; Hai L; Wu Y; Hu HY; Zhang ZR
J Drug Target; 2005 Feb; 13(2):121-8. PubMed ID: 15823963
[TBL] [Abstract][Full Text] [Related]
5. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
6. Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells.
Han J; Il Yeom Y
Int J Pharm; 2000 Jul; 202(1-2):151-60. PubMed ID: 10915938
[TBL] [Abstract][Full Text] [Related]
7. Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes.
Cao G; Kuriyama S; Du P; Sakamoto T; Yang W; Masui K; Qi Z
J Gastroenterol Hepatol; 1996 Nov; 11(11):1053-61. PubMed ID: 8985830
[TBL] [Abstract][Full Text] [Related]
8. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
9. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates.
Kim TG; Kang SY; Kang JH; Cho MY; Kim JI; Kim SH; Kim JS
Bioconjug Chem; 2004; 15(2):326-32. PubMed ID: 15025528
[TBL] [Abstract][Full Text] [Related]
12. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
[TBL] [Abstract][Full Text] [Related]
13. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells.
He P; Tang ZY; Ye SL; Liu BB; Liu YK
J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid.
Singh M; Kisoon N; Ariatti M
Drug Deliv; 2001; 8(1):29-34. PubMed ID: 11280441
[TBL] [Abstract][Full Text] [Related]
15. In vivo transfection of hepatitis C virus complementary DNA into rodent liver by asialoglycoprotein receptor mediated gene delivery.
Yamamoto M; Hayashi N; Miyamoto Y; Takehara T; Mita E; Seki M; Fusamoto H; Kamada T
Hepatology; 1995 Sep; 22(3):847-55. PubMed ID: 7657292
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes.
Han J; Lim M; Yeom YI
Biol Pharm Bull; 1999 Aug; 22(8):836-40. PubMed ID: 10480322
[TBL] [Abstract][Full Text] [Related]
17. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
18. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
[TBL] [Abstract][Full Text] [Related]
19. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
Díez S; Navarro G; de ILarduya CT
J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
[TBL] [Abstract][Full Text] [Related]
20. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]